Navigation Links
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Date:5/12/2010

SCHAUMBURG, Ill., May 12 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free, latex-free, single-dose vial packaged both individually and in packages of ten.  These vials will feature Sagent's proprietary PreventIV Measures™ labeling and packaging, with distinctive labeling designs and easy to read drug name and dosage information. The total 2009 U.S. market for injectable bacitracin approximated $32 million, according to IMS data. Sagent expects to launch bacitracin in the third quarter of 2010.  

"Sagent is well positioned to meet the needs of the growing hospital anti-infective market. Including bacitracin, our anti-infective product line now encompasses nine products," said Jeffrey M. Yordon, Sagent's chief executive officer, founder, and chairman of the board. "To provide pharmacies of all types with the flexibility they require to stock bacitracin appropriate to their individual needs, Sagent will offer the product in both single units and in convenient packs of ten."

Bacitracin marks the seventh product approved from Sagent's partnership with Strides Arcolab.  Under this venture, Sagent and Strides Arcolab are jointly developing, supplying and marketing more than 25 injectable products for the U.S. market.  Strides is responsible for developing and manufacturing injectable products that Sagent will market in the United States.

About Bacitracin for injection, USP

The use of intramu
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial
2. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
3. Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
4. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
5. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
6. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
8. Onyx Pharmaceuticals to Present at the Baird 2010 Growth Stock Conference
9. JHP Pharmaceuticals Announces Successful Completion of FDA and EMEA GMP Audits
10. Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
11. S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
(Date:6/19/2013)... Adding to their already extensive supply of ... Dropette® and Heathrow Scientific disposable plastic transfer ... biology, chemistry and any type of liquid handling analysis ... years, Simport has been supplying the science community with ... Simport Dropette®. Simport’s Dropette® is a one-piece plastic ...
(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13
... be Addressed by Board and Management on Avigen,s February ... Biotechnology Value Fund, L.P. ("BVF"), today called for ... ) to address certain fundamental questions BVF believes need ... evaluate Avigen,s future strategic direction. Avigen announced in ...
... Jennerex, Inc. (San Francisco, CA,and Ottawa, Canada) a ... Reviews Cancer, has published an article about,the company,s ... encouraging clinical and preclinical data. The article,published ... David H. Kirn, M.D.,president and chief executive officer ...
... System Will Continue to Fuel Growth and Generate CashNEW YORK, ... Vice President James C. Borel said today he expects DuPont ... share by at least 1 to 2 points in 2009 ... DuPont Agriculture & Nutrition segment an average of at least ...
Cached Biology Technology:Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 2Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 3Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 4Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 5Nature Reviews Publishes Article About Jennerex's Multi-Mechanistic Cancer Therapeutic 2Nature Reviews Publishes Article About Jennerex's Multi-Mechanistic Cancer Therapeutic 3DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 2DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 3DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 4DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth 5
(Date:6/19/2013)... A decade-long JDRF-funded study led by the Institute ... is providing a deeper understanding of the link ... 1 diabetes (T1D), highlighting the importance of pre-diabetes ... study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... today in The Journal of the American ...
(Date:6/19/2013)... Cornell University study offers further proof that the divergence ... million years ago was profoundly influenced by mutations to ... and off. , The study, published June 9 in ... hypothesis that regulation of genes must play an important ... humans and chimps in the proteins produced by genes. ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
Breaking Biology News(10 mins):New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2
... dinosaur skeleton found 24 years ago in Montana ... North American,dinosaurs with Asian dinosaurs. The dinosaur would have ... stood about three feet tall. The fossil,came from sediment ... on the finding was published in September,s issue of ...
... Exeter and Shimane University in Japan have proved for ... plant growth. This discovery could have implications for agriculture ... The study, which is now published online in ... which produces vitamin C, or ascorbate, in plants. Vitamin ...
... Sept. 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) ... announced that it has acquired a patent that ... portable locks. The company believes that this ... many years, consumers have been using portable locks, ...
Cached Biology News:New dinosaur species found in Montana 2Study shows vitamin C is essential for plant growth 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
... optimized for maximum packaging efficiencies of T7Select ... extracts (> 109 pfu/g with control DNA) ... containing at least 5 107 recombinant ... made from a specially designed phage that ...
... Mouse/Rat Tissue Extract Protein Array Kit is ... tissue extracts. The expression of a protein ... protein specific antibody. When the antibody binds ... a sensitive chemiluminescent or fluorescent signal created ...
... offers pre-validated SNP sequencing ... amplicons within 93 genes ... and more than 80 ... assays were developed and ...
Biology Products: